Why the study?
Evidence supporting bedside assessment and nursing processes for bleeding and thrombotic risks during neonatal ECMO needed to be mapped to identify priorities for evaluating a conceptual framework complementary to existing consensus guidance.
Population
111 sources covering neonates receiving extracorporeal membrane oxygenation
Design
Scoping review following JBI methodology and PRISMA-ScR across eight databases
Answers are grounded in this paper and cite their sources.
Scoping review maps bedside bleeding and thrombosis management during neonatal ECMO, highlighting major gaps in nursing escalation protocols.
Objective To map evidence supporting bedside assessment and nursing processes for bleeding and thrombotic risks during neonatal extracorporeal membrane oxygenation (ECMO), and identify priorities for evaluating a conceptual framework complementary to existing consensus guidance. Methods Following JBI methodology and PRISMA-ScR, eight databases were searched through July 1, 2026, with a PubMed update on August 6 and supplementary cross-validation. One reviewer screened and charted the evidence; a second author audited selected high-risk items and study-selection arithmetic. Registration was retrospective. Evidence was stratified as neonatal-specific or applicability evidence and mapped to 11 conceptual components. Results The review included 111 sources: 67 (60.4%) neonatal-specific and 44 (39.6%) applicability sources. No single coagulation assay represented anticoagulant effect, global hemostasis, patient events, and circuit condition. Source coverage was sparse for medication safety, graded escalation, within-scope nursing responses, and handover or quality improvement, with respective neonatal-specific counts of 1, 1, 2, and 0. These counts describe reported content, not evidence certainty or intervention effectiveness. Conclusion The review identifies an implementation-focused research question alongside PEACE: how monitoring information is verified, assessed, communicated, and reassessed in neonatal care. The proposed framework separates measurement verification from emergency escalation; verification must not delay urgent team assessment, and clinical deterioration is not a prerequisite for escalation. Its categories are unvalidated and do not authorize treatment changes. Operational definitions, reliability testing, and prospective process and safety evaluation are required before implementation as a clinical pathway. Systematic Review Registration https://doi.org/10.37766/inplasy2026.8.0027, identifier INPLASY202680027
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: